WallStSmart

Nova Ltd (NVMI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nova Ltd generates 240% more annual revenue ($880.58M vs $258.90M). NVMI leads profitability with a 29.4% profit margin vs -15.5%. NVMI earns a higher WallStSmart Score of 68/100 (B-).

NVMI

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 9.0Value: 4.3Quality: 8.0
Piotroski: 5/9Altman Z: 3.69

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for NVMI.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVMI5 strengths · Avg: 8.8/10
Altman Z-ScoreHealth
3.6910/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
23.1%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
29.4%9/10

Keeps 29 of every $100 in revenue as profit

Operating MarginProfitability
27.7%8/10

Strong operational efficiency at 27.7%

EPS GrowthGrowth
22.4%8/10

Earnings expanding 22.4% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

NVMI2 concerns · Avg: 3.0/10
Price/BookValuation
12.1x4/10

Trading at 12.1x book value

P/E RatioValuation
62.9x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : NVMI

The strongest argument for NVMI centers on Altman Z-Score, Return on Equity, Profit Margin. Profitability is solid with margins at 29.4% and operating margin at 27.7%. Revenue growth of 14.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : NVMI

The primary concerns for NVMI are Price/Book, P/E Ratio. A P/E of 62.9x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NVMI profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.

NVMI carries more volatility with a beta of 1.79 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SEMICONDUCTOR EQUIPMENT & MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NVMI scores higher overall (68/100 vs 41/100), backed by strong 29.4% margins and 14.3% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nova Ltd

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Nova Measuring Instruments Ltd. designs, develops, produces, and sells process control systems used in semiconductor manufacturing in Israel, Taiwan, the United States, China, Korea, and internationally. The company is headquartered in Rehovot, Israel.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?